CG MedTech Co.,Ltd. (KOSDAQ:056090)
1,517.00
+42.00 (2.85%)
At close: Jan 29, 2026
CG MedTech Market Cap
CG MedTech has a market cap or net worth of 165.21 billion as of January 30, 2026. Its market cap has increased by 51.66% in one year.
Market Cap
165.21B
Enterprise Value
152.48B
Revenue
45.59B
Ranking
n/a
PE Ratio
49.08
Stock Price
1,517.00
Market Cap Chart
Since November 12, 2015, CG MedTech's market cap has decreased from 171.35B to 165.21B, a decrease of -3.58%. That is a compound annual growth rate of -0.36%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 29, 2026 | 156.64B | 29.88% |
| Dec 30, 2025 | 120.61B | 15.87% |
| Dec 30, 2024 | 104.09B | 129.46% |
| Dec 30, 2021 | 45.36B | 26.28% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| DuChemBIO | 255.39B |
| T&R Biofab | 163.16B |
| OSTEONIC | 128.59B |
| JW Shinyak | 112.30B |
| Sewoon Medical | 103.47B |
| SCL Science | 78.75B |
| Wonbiogen | 47.88B |
| KM Corporation | 46.65B |